Due to a number of inquires, I will give an update this month on the Zofran litigation. Read more
U.S. District Judge F. Dennis Saylor IV said that claims about the Zofran’s labeling are sufficiently specific to pass muster. Read more
Judge Saylor denied GSK’s first Motion to Dismiss all of the pending Zofran cases on preemption grounds last year. Read more
Zofran is a powerful anti-nausea medication approved by the FDA for patients suffering from nausea as a side effect of chemotherapy. Read more
Zofran continues to be prescribed routinely for pregnant women suffering from morning sickness. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.